# Pierrepont Therapeutics, Inc. — Form D

Pierrepont Therapeutics, Inc. of BROOKLYN, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-15. The offering totals $5.9M, of which $2.1M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-04-15
- Form: D
- Accession: 0002019360-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.9M
- Amount sold: $2.1M
- Remaining: $3.8M
- Investors: 2
- Date of first sale: 2024-04-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-510659

## Issuer

- Name: Pierrepont Therapeutics, Inc.
- CIK: 0002019360
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: DOWNSTATE TECHNOLOGY CENTER, SUITE 327A, BROOKLYN, NY, 11203
- Phone: 212-430-1740

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Peter H Barber | Director | Brooklyn, NY |
| Daniel H DiPietro | Director | Brooklyn, NY |
| Matthew H Wyckoff | Director | Brooklyn, NY |
| Peter H Barber | Executive Officer | Brooklyn, NY |

## More

- [CIK 2019360 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2019360&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002019360-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.